References
- Abla N, Naik A, Guy RH, Kalia YN. (2005). Effect of charge and molecular weight on transdermal peptide delivery by iontophoresis. Pharm Res, 22: 2069–2078.
- Banga AK. (1998). Electrically Assisted Transdermal and Topical Drug Delivery (pp. 1–172 ). London: Taylor & Francis.
- Banga AK. (2006). New technologies to allow transdermal delivery of therapeutic proteins and small water-soluble drugs. Am J Drug Deliv, 4: 221–230.
- Banga AK. (2009). Microporation applications for enhancing drug delivery. Expert Opin Drug Deliv, 6: 343–354.
- Benson HAE, Namjoshi S. (2008). Proteins and peptides: strategies for delivery to and across the skin. J Pharm Sci, 97: 3591–3610.
- Cazares-Delgadillo J, Naik A, Ganem-Rondero A. Quintanar-Guerrero D, Kalia YN. (2007).Transdermal delivery of cytochrome C—A 12.4 kDa protein—across intact skin by constant-current iontophoresis. Pharmaceutical Res, 24: 1360–1368.
- Chaturvedula A, Joshi DP, Anderson C, Morris RL, Sembrowich WL, Banga AK. (2005). In vivo iontophoretic delivery and pharmacokinetics of salmon calcitonin. nt J Pharm, 297: 190–196.
- Cormier M, Johnson B, Ameri M, Nyam K, Libiran L, Zhang DD, Daddona P. (2004). Transdermal delivery of desmopressin using a coated microneedle array patch system. J Control Release, 97: 503–511.
- Cross SE, Roberts MS. (2004). Physical enhancement of transdermal drug application: is delivery technology keeping up with pharmaceutical development? Current Drug Deliv, 1: 81–92.
- Ito Y, Hagiwara E, Saeki A, Sugioka N, Takada K. (2006). Feasibility of microneedles for percutaneous absorption of insulin. Eur J Pharm Sci. 29: 82–88.
- Kolli CS, Banga AK. (2008). Characterization of solid maltose microneedles and their use for transdermal delivery. Pharm Res, 25: 104–113.
- Lin W, Cormier M, Samiee A, Griffin A, Johnson B, Teng CL, Hardee GE, Daddona PE. (2001). Transdermal delivery of antisense oligonucleotides with microprojection patch (Macroflux) technology. Pharm Res, 18: 1789–1793.
- Marc GPM, Brown B, Jones SA, Akomeah FK. (2006). Dermal and transdermal drug delivery systems: current and future prospects. Drug Delivery, 13: 75–187.
- Matriano JA, Cormier M, Johnson J, Young WA, Buttery M, Nyam K, Daddona PE. (2002). Macroflux microprojection array patch technology: a new and efficient approach for intracutaneous immunization. Pharm Res, 19: 63–70.
- Mitragotri S, Blankschtein D, Langer R. (1995). Ultrasound-mediated transdermal protein delivery. Science (New York, NY), 269: 850–853.
- Prausnitz MR. (2004). Microneedles for transdermal drug delivery. Adv Drug Deliv Rev, 56: 581–587.
- Schuetz YB, Naik A, Guy RH, Vuaridel E, Kalia YN. (2005). Transdermal iontophoretic delivery of triptorelin in vitro. J Pharm Sci, 94: 2175–2182.
- Shire S.J., Shahrokh Z., Liu J. (2004). Challenges in the development of high protein concentration formulations. J Pharm Sci, 93: 1390–1402.
- Tokumoto S, Higo N, Sugibayashi K. (2006). Effect of electroporation and pH on the iontophoretic transdermal delivery of human insulin. Int J Pharm, 326: 13–19.
- Taoand SL, Desai TA. (2003). Microfabricated drug delivery systems: from particles to pores. Adv Drug Deliv Rev, 55: 315–328.
- Widera G, Johnson J, Kim L, Libiran L, Nyam K, Daddona PE, Cormier M. (2006). Effect of delivery parameters on immunization to ovalbumin following intracutaneous administration by a coated microneedle array patch system. Vaccine, 24: 1653–1664.